Difference between revisions of "CTSC:education Cardiology"

From NAMIC Wiki
Jump to: navigation, search
Line 25: Line 25:
 
=== Sixth lecture: Clinical research with cardiovascular nuclear imaging (30 min including questions)===
 
=== Sixth lecture: Clinical research with cardiovascular nuclear imaging (30 min including questions)===
 
   
 
   
* Speaker: Marcello Di Carli (3/22), pending (3/23)
+
* Speaker: Marcello Di Carli (3/22), Henry Gewirtz (3/23)
+
 
 
=== Seventh lecture: Overview of utilizing the Harvard Catalyst Imaging Resources (15 min including questions/wrap up)===
 
=== Seventh lecture: Overview of utilizing the Harvard Catalyst Imaging Resources (15 min including questions/wrap up)===
 
   
 
   

Revision as of 04:07, 24 February 2010

Home < CTSC:education Cardiology

Back to Collaboration:Harvard_CTSC

Proposed structure for the Cardiovascular Imaging half-day sessions (Monday March 22nd, BWH and Tuesday March 23rd, MGH)

First lecture: Imaging biomarkers overview (15 min including questions)

  • Speaker: pending

Second lecture: Clinical research with cardiovascular ultrasound (30 min including questions)

  • Speaker: Todd Perlstein (3/22 and 3/23)

Third lecture: Clinical research with cardiovascular MRI (35 min including questions)

  • Speaker: Neil Rofsky (3/22 and 3/23)

Fourth lecture: Life cycle of medical imaging data (15 min including questions)

  • Speaker: pending

Fifth lecture: Clinical research with cardiovascular CT (30 min including questions)

  • Speaker: Ron Blankstein (3/22), pending (3/23)

Sixth lecture: Clinical research with cardiovascular nuclear imaging (30 min including questions)

  • Speaker: Marcello Di Carli (3/22), Henry Gewirtz (3/23)

Seventh lecture: Overview of utilizing the Harvard Catalyst Imaging Resources (15 min including questions/wrap up)

  • Speaker: Valerie Humblet

Regarding goals to share with the individual imaging modality speakers

  • To provide a brief technical overview of the imaging modality.
  • To provide an overview of the imaging biomarkers that the modality can generate.
  • To provide one or two specific examples of the use of that modality in answering a clinical research question.
  • To provide an overview of technical and / or logistical issues in utilizing the modality.
  • Cost?
  • To address subject safety issues with that modality